NEW YORK, NY / ACCESS Newswire / February 14, 2025 / Mid Atlantic Retina recently disclosed that it suffered a data breach that compromised the ...
Our lead program 4D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and anti-VEGF-C) targeted to the retina with a single ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results